Inhibitor Therapeutics (INTI) SEC Filings & 10K Form $0.06 +0.01 (+20.00%) As of 04/1/2025 01:04 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock Recent Inhibitor Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView02/19/20258:28 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)MCNULTY JAMES A (Reporting)Form 5Annual statement of changes in beneficial ownership of securities 02/19/20258:27 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Yanez Michelle (Reporting)Form 5Annual statement of changes in beneficial ownership of securities 11/12/20245:27 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/06/20248:30 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Jerman Michael Allen (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)OSMAN RONALD E (Reporting)Ronald E Osman Irrevocable Trust III (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)SEARS SAMUEL P JR (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)MCNULTY JAMES A (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Yanez Michelle (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/13/20248:00 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Remove Ads Related Companies and Tools Related Companies ATRA 10Q Form VRCA 10Q Form LTRN 10Q Form DYAI 10Q Form SCYX 10Q Form MDCX 10Q Form ELYM 10Q Form KALA 10Q Form RNTX 10Q Form ALXO 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:INTI) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibitor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INTI Stock Free INTI Stock Alerts